Where Oncology Pharmacists, Residents, & Technicians access Chemotherapy Drug Information, Products, & Programs
OncologyPharmacist.NET is dedicated to providing timely information, consulting services, and links for Clinical Hem/Onc/BMT Pharmacists, Residents, and Technicians, in a single location, to be used on a daily basis. Improving Patient Care through the exchange of information is our goal. Our News and Clinical Tools sections will come from practice sites throughout the world. Our Job Boards will focus on relevant positions exclusively. Our Patient Assistant Programs area will link to sites that provide drugs that are used strictly in Hematology and Oncology. New Drugs will highlight Chemotherapy and Supportive Care drugs with new indications within the last 365 days. Our hope is to integrate CMS coding and announcements in the future as well as provide an area for Hem/Onc/BMT Residents, Technicians, and Practitioners to exchange ideas. Please bookmark our site, sign up to be listed on our Advisory Board Clinicians or Speakers List, send us suggestions or guidelines to improve the site, and consider advertising in this exciting domain. OP
NewsfeedCancer / Oncology News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.
'New drug target for leukemia identified'
The largest ever genetic analysis of childhood blood cancer has unveiled a strand of RNA that could be targeted by drugs to slow progression of leukemia.
Breakthrough in measuring how cancer support programs empower survivors
Cancer support services world-wide are, for the first time, able to measure the benefits of their programs in empowering patients to manage their illness, thanks to the work of Deakin University...
The efficiency of tissue regeneration may be increased by stem cell advance
A new stem-cell discovery might one day lead to a more streamlined process for obtaining stem cells, which in turn could be used in the development of replacement tissue for failing body parts...
Blood and saliva test for HPV-related cancers 'in development'
Johns Hopkins researchers have achieved 70% accuracy with a new blood and saliva test for predicting recurrence of HPV-related cancers. However, further refinements are needed.
Merck Serono initiates phase II study of anti-PD-L1 antibody MSB0010718C in m...
Merck Serono, the biopharmaceutical division of Merck, today announced the initiation of an international Phase II study designed to assess the efficacy and safety of MSB0010718C, an...
Newsfeed display by CaRP
|Headquarters: Warwick, RI • ©2009 OncologyPharmacist.net|